00376nas a2200085   4500000000100000008004100001260002300042100001900065245020600084       2016                            d  aWashington DC, USA1 aPerkovic Vlado00aDiabetes type 2 CV outcome trials. Time to transition from non-inferiority safety to superiority efficacy trials? Session- Diabetes Outcome Trials. Transitioning to CV efficacy Trials [invited speaker]